Trial Profile

Comparison of strut coverage between previous generation durable polymer everolimus-eluting stent (XIENCE ) and new generation bioabsorbable polymer everolimus-eluting stent (SYNERGY) in patients with acute coronary syndrome at 2 weeks and 4 months after stent implantation

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 23 Jun 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

30 Sep 2017 New trial record
30 Aug 2017 Results (N= 45 , 25 patients with Xience and 22 patients with Synergy for serial optical coherence tomography analysis) presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com